ORIC Pharmaceuticals, Inc. (ORIC) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$10.98
Day's range
$12.95

ORIC Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
NEXTECH INVEST, LTD. 08/14/2026 7.16 M $77.57 M   0.00% 6.63%
BLACKROCK, INC. 08/07/2026 6.82 M $73.90 M   14.03% 6.32%
ECOR1 CAPITAL, LLC 08/14/2026 6.73 M $72.87 M   0.00% 6.23%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 6.62 M $71.67 M   22.83% 6.13%
VIKING GLOBAL INVESTORS LP 08/14/2026 5.13 M $55.52 M   -11.98% 4.75%
STATE STREET CORP 08/07/2026 4.89 M $53.00 M   32.19% 4.53%
SR ONE CAPITAL MANAGEMENT, LP 08/12/2026 4.62 M $49.98 M   2.23% 4.27%
VR ADVISER, LLC 08/14/2026 4.32 M $46.78 M   0.00% 4.00%
NEA MANAGEMENT COMPANY, LLC 08/14/2026 4.12 M $44.60 M   0.00% 3.81%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 3.95 M $42.79 M   7.16% 3.66%
AIHC CAPITAL MANAGEMENT LTD 08/13/2026 3.83 M $41.46 M   55.66% 3.54%
ALKEON CAPITAL MANAGEMENT LLC 08/14/2026 3.74 M $40.49 M   -16.98% 3.46%
COLUMN GROUP LLC 08/14/2026 3.54 M $38.35 M   0.00% 3.28%
SIREN, L.L.C. 08/13/2026 3.00 M $32.47 M   0.00% 2.78%
FMR LLC 08/13/2026 2.64 M $28.54 M   8.27% 2.44%
CITADEL ADVISORS LLC 09/02/2026 2.60 M $28.11 M   7.12% 2.40%
GOLDMAN SACHS GROUP INC 08/14/2026 2.45 M $26.55 M   66.14% 2.27%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 2.09 M $22.64 M   13.67% 1.94%
FIRST TURN MANAGEMENT, LLC 08/14/2026 2.02 M $21.85 M   0.00% 1.87%
ORBIMED ADVISORS LLC 08/14/2026 2.02 M $21.82 M   -25.20% 1.87%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 08/14/2026 1.90 M $20.58 M   35.71% 1.76%
BIOIMPACT CAPITAL LLC 08/14/2026 1.88 M $20.38 M   4.34% 1.74%
VIVO CAPITAL, LLC 08/14/2026 1.85 M $20.02 M   0.00% 1.71%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 1.80 M $19.50 M   22.44% 1.67%
FRANKLIN RESOURCES INC 08/13/2026 1.80 M $19.47 M   23.72% 1.66%
MORGAN STANLEY 08/13/2026 1.79 M $19.43 M   6.63% 1.66%
D. E. SHAW & CO., INC. 08/14/2026 1.58 M $17.11 M   3,459.85% 1.46%
WOODLINE PARTNERS LP 08/14/2026 1.25 M $13.51 M   0.00% 1.16%
ALGERT GLOBAL LLC 08/13/2026 1.22 M $13.16 M   791.30% 1.13%
BRAIDWELL LP 08/14/2026 1.21 M $13.15 M   7.67% 1.12%
CANDRIAM S.C.A. 08/13/2026 1.18 M $12.76 M   105.50% 1.09%
BANK OF AMERICA CORP /DE/ 08/14/2026 1.08 M $11.68 M   3.35% 1.00%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 1.05 M $11.39 M   205.51% 0.97%
DEFILADE CAPITAL MANAGEMENT, L.P. 08/14/2026 1.05 M $11.35 M   24.29% 0.97%
EUCLIDEAN CAPITAL LLC 08/14/2026 989.41 K $10.72 M   0.00% 0.92%
ROYCE & ASSOCIATES LP 08/14/2026 979.66 K $10.61 M   -18.85% 0.91%
EVENTIDE ASSET MANAGEMENT, LLC 08/14/2026 954.77 K $10.34 M   0.14% 0.88%
NORTHERN TRUST CORP 08/13/2026 806.30 K $8.73 M   13.43% 0.75%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 794.54 K $8.60 M   -7.56% 0.74%
SPHERA FUNDS MANAGEMENT LTD. 08/14/2026 752.98 K $8.15 M   40.06% 0.70%
JONES HILL CAPITAL LP 08/13/2026 747.31 K $8.09 M   100.00% 0.69%
SILVERARC CAPITAL MANAGEMENT, LLC 08/13/2026 738.87 K $8.00 M   -32.83% 0.68%
NEXTBIO CAPITAL MANAGEMENT LP 08/14/2026 706.12 K $7.65 M   34.85% 0.65%
MILLENNIUM MANAGEMENT LLC 08/14/2026 697.69 K $7.56 M   1,951.32% 0.65%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 677.82 K $7.34 M   12.03% 0.63%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 677.82 K $7.34 M   100.00% 0.63%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 628.68 K $6.81 M   10.16% 0.58%
TWO SIGMA INVESTMENTS, LP 08/14/2026 603.66 K $6.54 M   100.00% 0.56%
ARROWMARK COLORADO HOLDINGS LLC 08/13/2026 582.88 K $6.31 M   -39.32% 0.54%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 566.04 K $6.13 M   11.58% 0.52%

ORIC Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 233 institutional investors and hedge funds held shares of ORIC Pharmaceuticals Inc. The most heavily invested institutionals were:

Nextech Invest, Ltd.: 7.16 M

BlackRock, Inc.: 6.82 M

EcoR1 Capital, LLC: 6.73 M

PRICE T ROWE ASSOCIATES INC /MD/: 6.62 M

VIKING GLOBAL INVESTORS LP: 5.13 M

STATE STREET CORP: 4.89 M

115.02% of ORIC Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 147.26 M shares in the last 24 months. This purchase volume represents approximately $1.72 B in transactions.